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Abstract
Background: Oligosaccharide processing enzymes are important
classes of catalysts involved in synthesizing specific oligosaccha-
ride structures on proteins and sphingolipids. Development of
specific inhibitors of such enzymes is of current interest as these
inhibitors may be used to control cellular functions. Five-
membered iminocyclitols have been shown to be potent inhibitors
of such enzymes. Since a rational design and synthesis of inhibitors
is often extremely difficult due to the limited information
regarding the structure of the active site, we carried out a
combinatorial library approach.
Results : To create diversity, we decided to use an aldehyde
group of a protected iminocyclitol for reductive amination and the
Strecker reaction. After transformation of the nitrile group
introduced by the Strecker reaction into an amine and amide
and complete deprotection, a small library of five-membered
iminocyclitols consisting of 27 compounds was synthesized. A
series of compounds obtained by reductive amination was first
screened as potential inhibitors of glycosidases and glycosyltrans-
ferases. Among them, compounds carrying a C10-alkyl group
showed marked enhancement of inhibitory activity against K-
mannosidase at 10 WM concentration when compared with its
parent compound and deoxymannojirimycin. Furthermore, com-
pounds having the phenylethyl group showed an extremely strong
inhibitory effect against K-galactosaminidase at a Ki value of 29.4
nM. Compounds with an aminomethyl and amide group at the C-
1P position of these two molecules showed a decrease in inhibitory
activities.
Conclusions: A combinatorial approach based on five-mem-
bered iminocyclitols with a galacto-configuration was exploited.
The potential usefulness of the library as a source of inhibitors of
glycoenzymes is clearly shown in this study. ß 2001 Elsevier
Science Ltd. All rights reserved.
Keywords: Combinatorial library; Glycosidase; Glycosyltrans-
ferase; Iminocyclitol ; Inhibitor
1. Introduction
Enzymes to synthesize and process oligosaccharides
such as glycosyltransferases and glycosidases are impor-
tant classes of catalysts involved in the assembly of speci¢c
oligosaccharide structures on proteins [1,2] and sphingo-
lipids [3]. Development of speci¢c inhibitors of such en-
zymes is of current interest as these inhibitors may be used
to control cellular functions. Enzymatic hydrolysis of a
glycosidic bond generally takes place via general acid
and base catalysis that requires two critical residues, a
proton donor and a nucleophile [4^6]. A distorted half-
chair-like transition state leading to a carboxonium ion
is considered to be involved in the reaction (Fig. 1).
Five-membered iminocyclitols carrying hydroxyl groups
with speci¢c orientation to mimic the shape and charge
of the transition state of the reacting sugar moiety have
been shown to be potent inhibitors of such enzymes [7^12].
Since a cation-like transition state is expected to be in-
volved in both the glycosyltransferase- and glycosidase-
catalyzed reactions, ¢ve- and six-membered iminocyclitols
can be used as core components for the development of
transition-state analog inhibitors of both families of en-
zymes [7^19].
During the course of our investigation toward this goal,
we synthesized a series of ¢ve-membered iminocyclitols
and have shown that some of them possess strong and/
or interesting inhibitory activities against glycosyltransfer-
ases and glycosidases [11,12]. Since a rational design and
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synthesis to a¡ord desired inhibition is often extremely
di⁄cult due to the limited information regarding the struc-
ture of the active site, we considered another potential
approach based on a combinatorial library derived from
a ¢ve-membered iminocyclitol. Despite the potential use-
fulness of the library strategy, there is a chance that none
of a series of compounds is inhibitory. Therefore, we de-
cided to focus ¢rst on creating a small, but diverse, group
of compounds to test as potential inhibitors of glycoen-
zymes. Here, we report the synthesis of a ¢ve-membered
iminocyclitol library of galacto-con¢guration and subse-
quent evaluation of their inhibition against various glyco-
sylhydrolases and glycosyltransfer enzymes such as K-glu-
cosidase (Glc-ase; EC 3.2.1.20), K-mannosidase (Man-ase,
EC 3.2.1.24), K-galactosidase (Gal-ase, EC 3.2.1.22) and
L-Gal-ase (EC 3.2.1.23), K-GalNAc-ase (EC 3.2.1.49), L-
1,4-galactosyltransferase (L-1,4-GalT-ase; EC 2.4.1.22)
and K-1,3-galactosyltransferase (K-1,3-GalT-ase; EC
2.4.1.90).
2. Results and discussion
2.1. Synthesis of a combinatorial library
In this study, we selected a ¢ve-membered iminocyclitol
with a 2(R), 3(R), 4(S), 5(R)-con¢guration which is re-
ferred to as either the ‘galacto’-form (1a) or the ‘manno’-
form (1b) depending on the conformation of the pyrroli-
dine ring (Fig. 2). The ¢ve-membered ring system is
known to be conformationally more £exible than the six-
membered system and exists as an equilibrium of various
conformers at physiological conditions, thus both con-
formers (1a and 1b) may have to be considered as struc-
tural candidates for the inhibition study on glycoenzymes.
This ¢ve-membered system can be considered advanta-
geous as a lead structure for the combinatorial library,
where further speci¢city and a⁄nity can be developed by
incorporation of additional functionalities in structure 2.
We considered that these conformers (2a and 2b) may be
treated as ‘conformational diversity factors’ in the library
because di¡erent conformers are thought to interact with
the corresponding enzyme families regarding their binding
speci¢cities (Fig. 3).
Few approaches have been reported regarding carbohy-
drate-related libraries targeting glycoenzymes so far [20^
25]. Approaches based on transition state inhibitors [21^
24] are our particular interest. Several possibilities exist
regarding how diversity is generated, i.e. linear type (in-
volving iterative reactions of doubly functionalized syn-
thetic units), sca¡old type (involving reactions of a tem-
plate with multiple functional groups) and cascade type (a
reaction product gives an additional function for the next
reaction) [26]. Considering that a series of molecules of
our interest have a low molecular weight and should ¢t
in the primary catalytic site of the target enzyme, which
covers approximately 100 Aî 2 of the protein surface ac-
cording to the available crystallographic data of related
enzymes [27^31], we thought that the added functionalities
in the created molecule should not be scattered but rather
condensed close to the core unit, an iminocyclitol in this
study. Based on these considerations, we took the third
strategy for our library synthesis.
To create diversity based on compound 1, we decided to
use the aldehyde group at the C-1P position. The decision
was based on our previous observation that N-alkylation
of the ring nitrogen often resulted in decreased inhibitory
activity at the molecular level [11,12], although increased
hydrophobicity is advantageous for penetrating the cell
membrane [32^34]. Aldehyde 3 was thus synthesized as
reported in our previous paper and used to create a library
[12]. First, we designed and utilized imines formed by re-
action of 3 and amines for various reaction conditions
including reductive amination, Strecker condensation,
Ugi-type reaction and Mannich reaction as well as subse-
quent introduction of polyethylene glycol by acylation of
Fig. 1. Diagram of the transition state of the enzymatic hydrolysis reac-
tion of the glycoside. The hydrolysis reaction involves a distorted half-
chair conformation in the transition state.
Fig. 2. Five-membered iminosugar 1 and two possible conformers. Com-
pound 1 can be considered either a galactose or a mannose mimic.
Equilibrium exists among conformers. Thus, ¢ve-membered iminocycli-
tols are considered advantageous because ‘one compound’ can be a can-
didate to inhibit di¡erent enzymes with di¡erent stereospeci¢cities.
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the products to enhance the diversity and to ease the ‘¢sh-
out’ process of the condensation product from a reaction
mixture. However, as we examined these reactions, we
found that some of the reactions did not give satisfactory
results. It was suggested that this was due to the severe
steric problems of t-butylcarbonyl (Boc), benzyl (Bn) and
X of amines around the reaction site. Reactions which
were found to be applicable in the synthesis were reductive
amination and the Strecker reaction without subsequent
acylation. Thus, we could not gain a large diversity in
the iminocyclitol-based library but alternatively considered
including transformation reactions of a nitrile group into
amine, amide and carboxylic acid (Ys). The selected X and
Y groups are shown in Fig. 3.
At ¢rst, reductive amination reactions of 3 using a vari-
ety of amines (X-H) were carried out. Reduction of the
imine proceeded smoothly under standard conditions with
sodium cyanoborohydride to give compounds 4(1^9),
which were deprotected in one step by hydrogenolysis
under acidic conditions to a¡ord compounds 2(1^9,1) in
good yields after puri¢cation using a Sep-Pak CM car-
tridge. The individual conversion rate of the reductive
amination reaction was estimated by densitographic anal-
ysis of the TLC plate, which indicated that compound 3
was transformed into 4 in a range of 42^98% yield.
Next, the Strecker reaction was carried out. Trimethyl-
silylcyanide (TMSCN) was used in the presence of cata-
lytic ZnCl2 after imine formation with nine amines [35]
(Scheme 1, Fig. 3). It was found that reactions did not
proceed without Lewis acid. No signi¢cant stereoselectiv-
Fig. 3. Diagram of a combinatorial library. At the C-1P position a diversity was introduced (X,Y). The series of compounds 2(X,Y) share a ¢ve-mem-
bered iminosugar which may exist in equilibrium with the galacto-conformer 2a and the manno-conformer 2b.
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ity was observed in any case, which suggested that Lewis
acid directly activated the imine intermediate but not
through other functional groups since auxiliary e¡ects
could not be observed. The condensation products were
subjected to the following reactions without isolation. The
conversion rate of the aldehyde 3 into 5 was in the range
of 57^97% according to densitography. The mixtures were
subjected to various reaction conditions such as hydrolysis
and reduction to transform the nitrile group into a carbox-
ylate, amide or amine. Reduction of 5(1^9) to convert
amine 2(1^9,2) was achieved under acidic hydrogenolysis
conditions, which removed the Boc and Bn groups at the
same time. When we attempted to hydrolyze the nitrile
group to obtain a carboxylic acid and amide (Y), both
acidic and basic hydrolytic conditions gave complex mix-
tures. Thus, 5(1^9) were converted oxidatively into amides,
which were then hydrogenolyzed to 2(1^9,3). Further
transformation of the intermediate to carboxylate failed
under these conditions, even after raising the temperature.
Having a series of compounds in hand, we selected en-
zymes to be examined using compounds 2(1^9,1) as po-
tential inhibitors. K-Gal-ase, L-Gal-ase and K-GalNAc-ase
were chosen as the counterparts of the galacto-conformer
2a(X,Y) (Fig. 3). Two glycosyltransferases, L-1,4-GalT-ase
and K-1,3-GalT-ase, were also included because com-
pound 1 was an inhibitor of L-1,4-GalT-ase against
UDP-Gal with a Ki value of 27 WM [12]. In the same
manner, K-Man-ase was selected for analysis of the man-
no-conformer 2b(X,Y). K-Glc-ase was also added to verify
other factors.
2.2. Screening of the library against glycoenzymes
In order to assay the inhibitory activities of the library
compounds against K-1,3-galactosyltransferase [36^39], the
required substrate and the product were ¢rst synthesized
enzymatically. 4-Methylumbelliferyl (4-MU-) LacNAc (6)
was ¢rst synthesized according to our previous report [40]
and was used as the substrate. Formation of 4-MU-Gal-
K(1C3)-Gal-L(1C4)-GlcNAc (7) during the reaction of 6
and UDP-Gal in the presence of the transferase was con-
¢rmed using capillary electrophoresis. Although we did
not isolate 7, we carried out MALDI-TOF mass spectral
analysis of the reaction mixture after Sep-Pak C18 to con-
¢rm the presence of 6 and 7.
To examine the potential of the strategy and each mem-
ber of the library as an inhibitor of glycosidases and gly-
cosyltransferases, we carried out preliminary inhibition
screening assays at a ¢xed concentration of potential in-
hibitors. The suitable concentration in each enzyme reac-
tion was determined by an initial inhibition test using a
representative compound in a library and/or known inhib-
itor of the enzyme at various concentrations. The inhib-
itory activity was shown as a percentage at the concentra-
tion determined. Each enzyme reaction was performed in a
well of a titer plate and the inhibitory activity against the
corresponding substrates was estimated by absorbance at
405 nm for p-nitrophenol in the case of glycosidases. Com-
mon inhibitors were used for the generality of the result
when they were available.
For the inhibition assay of transferases, we used the
corresponding substrate 4-MU-glycosides such as 4-MU-
GlcNAc, 4-MU-LacNAc (6) and 4-MU-Gal-K(1C3)-Gal-
L(1C4)-GlcNAc (7). Inhibition reactions were carried out
in microcentrifuge tubes for 5 min and the inhibitory ac-
tivities were determined as the conversion rate relative to
the acceptor substrate using capillary electrophoresis at
214 nm.
Scheme 1. Synthesis of a library consisting of 2(X,Y). Reductive amination and Strecker reaction of aldehyde 3 gave 4(X) and 5(X). The nitrile group
of compounds 5(X) was further transformed to amine- and amide-functional groups for Y. Deprotection of these compounds a¡orded 2(X,Y).
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As shown in Fig. 4, a series of compounds in the library
showed broad inhibitory spectra for the enzymes tested
except for K-1,3-GalT-ase for which the graph was omitted
as no inhibition was observed. Depending on the enzyme,
some compounds showed a dramatic enhancement of in-
hibition compared to the parent compound 1. Such exam-
ples can be found for K-Glc-ase (A), K-Man-ase (B), K-
GalNAc-ase (D) and L-Gal-ase (E, F). For the inhibition
of K-Glc-ase with an inhibitor concentration of 100 WM,
some were found to have activity twice as potent as 1
Fig. 4. Inhibitory activities of compounds 2(X,1) against various glyco-enzymes. (A) Inhibition of K-Glc-ase at an inhibitor concentration of 1U1034
M; (B) K-Man-ase at 1U1035 M; (C) K-Gal-ase at 1U1035 M; (D) K-GalNAc-ase at 1U1037 M; (E, F) L-Gal-ase at 1U1033 M and at 1U1035 M,
respectively; (G) L-1,4-GalT-ase at 5U1034 M. The synthesis of compounds 1 and 8 has been reported in [12].
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although none showed comparable inhibition to deoxyno-
jirimycin (DNJ). It was found that addition of a hydro-
phobic group far from the iminosugar is preferred in the
case of K-Man-ase, where compound 2(3,1) with a C10-
alkyl group showed 276% and 1120% increases in inhibi-
tion at 10 WM concentration against compound 1 (Ki = 27
WM) [12] and deoxymannojirimycin (DMN, Ki = 43 WM)
[12], respectively. For the inhibition of K-GalNAc-ase,
only the siastatin B analog has been reported to be an
inhibitor with an IC50 value in the WM range [41]. Strik-
ingly, ¢ve of the eight compounds were found to be more
than twice as potent compared to their parent compound
(1) in the nM order. Among them, compound 2(8,1), hav-
ing a phenethyl group, showed a 467% increase in activity.
Further kinetic analysis of 2(8,1) revealed Ki = 29.4 nM
whereas the Km value of K-PNP-GalNAc was 0.65 mM.
In the case of L-Gal-ase, all the compounds tested were
found to be much better inhibitors of the enzyme com-
pared to 1 (Ki = 1.0 mM) [12], but they only exhibited
weak inhibition at the WM range as shown in Fig. 4F.
Also, it was suggested that the substitution at the C-1P
position was not important for the binding since there
was no signi¢cant di¡erence in activity among the series
of compounds. It is worth noting that some compounds
were inhibitory against L-GalT-ase despite the fact that
none inhibited K-GalT-ase even though these two enzymes
share UDP-Gal as the donor substrate and our com-
pounds are thought to mimic the donor transition state.
This result may re£ect the required geometry of cationic
species in the enzyme catalytic site of these enzymes: one
is an inverting and the other is a retaining enzyme regard-
ing the con¢guration of the transferred galactosyl residue.
Compounds shown to have strong inhibitory e¡ects
such as compounds 2(3,1) and 2(8,1) were selected as leads
for further evaluations to see the e¡ects of the Y group
(Fig. 5). Compounds 2(3,2) and 2(3,3) lost almost all in-
hibitory activity against K-Man-ase at the concentration
used for the assay of compound 2(3,1). Compounds
2(8,2) and 2(8,3) inhibited K-GalNAc-ase with 52.8%
and 50.5% of the inhibitory e¡ect of 2(8,1), respectively.
Although there is an important question to be answered ^
whether one of the diastereoisomers formed during the
Strecker reaction had superior inhibitory activity over
the other ^ we did not isolate the diastereomers based
on the considerations below. The aromatic ring is impor-
tant for the enhancement of a⁄nity. Similar inhibition
modes are expected for both isomers because the major
component in the structure is the same. The binding site
therefore is considered to be the same. Considering that no
obvious e¡ect of Y (Y: 2 or 3) was observed even though
the electron-withdrawing potential of each group was re-
versed, the newly introduced secondary amino group had
no e¡ect on the binding a⁄nity. Further, aminomethyl
and amide substitutions had no e¡ect. In this case, the
only considerable factor that can a¡ect the inhibitory ac-
tivity is steric e¡ects. If, for example, one of the isomers of
compound 2(8,2) was the only component responsible for
the observed inhibitory activity, the minor isomer should
have ca. 132% enhanced inhibitory activity over 2(8,1)
since an almost 3:2 ratio of diastereomers was formed
during the Strecker reaction. Although we cannot discount
the possibility, it is highly unlikely that this is the case
because linkages between C-1 and the aromatic ring (¢ve
bonds) can rotate while ¢xing the iminosugar component
and aromatic ring. Therefore, even if one isomer accounts
for all the inhibitory activity, the e¡ect is still too small
and thus we ceased experiments on this compound.
Finally, completely di¡erent inhibitory spectra were ob-
served for the enzymes tested, which indicates that the
selectivity can be controlled by the substituent group at
the C-1P position of the same core unit. In addition, these
compounds showed inhibitory activities against enzymes
whose substrate speci¢cities are for both the galacto- and
manno-series. This observation suggests that the pyrroli-
dine ring compounds can be treated as conformational
mixtures in a library, which may enhance the utility of
such compounds.
3. Signi¢cance
A potential combinatorial approach based on ¢ve-mem-
bered iminocyclitol with a 2(R), 3(R), 4(S), 5(R)-con¢gu-
ration was exploited using reductive amination and the
Strecker condensation reaction. The novel idea of a ‘con-
formational diversity factor’ in library design was pro-
posed because di¡erent conformers are thought to bind
to the corresponding enzymes with di¡erent substrate spe-
ci¢cities.
During the investigation, di⁄culties associated with the
bulky protecting groups near the reaction site were en-
countered, which limited the scope of reactions. However,
the usefulness of the library as a source of inhibitors of
glycoenzymes was clearly shown. Thus, the library can be
screened to ¢nd small molecules that modulate cellular
Fig. 5. Inhibitory activities of compounds 2(3,Y) and 2(8,Y) against K-
Man-ase and K-GalNAc-ase. Two series of compounds 2(3,Y) and
2(8,Y) were selected to evaluate the e¡ects of the Y group. (A) Inhibi-
tion of K-Man-ase at 1U1035 M. (B) K-GalNAc-ase at 1U1037 M.
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functions since K-Glc-ase, K-Man-ase and L-GalT-ase are
deeply involved in the glycan processing of glycoproteins
[1^3] together with the involvement of K-GalNAc-ase ac-
tivity in immunode¢ciency [42].
4. Materials and methods
4.1. Materials
The following enzymes were purchased as indicated: K-gluco-
sidase (K-Glc-ase; K-glucoside glucohydrolase; EC 3.2.1.20), Sac-
charomyces sp. (ToYoBo); K-mannosidase (K-Man-ase, K-D-man-
noside mannohydrolase; EC 3.2.1.24), jack bean (Sigma); K-
galactosidase (K-Gal-ase, K-D-galactoside galactohydrolase; EC
3.2.1.22), green co¡ee bean (Sigma); L-galactosidase (L-Gal-ase,
L-D-galactoside galactohydrolase; EC 3.2.1.23), Aspergillus ory-
zae (Sigma); K-GalNAc-ase (2-acetamido-2-deoxy-K-D-galacto-
side acetamidodeoxygalactohydrolase; EC 3.2.1.49) from chicken
liver (Sigma); L-1,4-galactosyltransferase (L-1,4-GalT-ase; EC
2.4.1.22), bovine milk (Sigma); K-1,3-galactosyltransferase (K-
1,3-GalT-ase; EC 2.4.1.90), porcine, recombinant, Escherichia
coli (Calbiochem). 4-Methylumbelliferyl 2-acetamido-2-deoxy-L-
D-glucopyranoside (4-MU-GlcNAc) was from Wako Pure Chem-
icals. UDP-galactose and uridine 5P-diphosphate (UDP) were
from Sigma. Cacodylic acid sodium salt, HEPES [2-{4-(2-hydroxy-
ethyl)-1-piperazinyl}ethanesulfonic acid], MES [2-(N-morpholi-
no)ethanesulfonic acid], MnCl2, sodium tetraborate, and potassi-
um hydroxide were from Nakalai Tesque Inc. Double deionized
water was prepared from a Milli-Q system (Millipore Corp.). Sep-
Pak cartridges were from Waters Corp. Millex-GV syringe ¢lters
(0.22 mmU4 mm i.d.) were purchased from Nihon Millipore Ltd.
4.2. General methods for chemical synthesis
Dried solvents were used for all reactions. Solutions were
evaporated under reduced pressure at a bath temperature not
exceeding 50‡C. Column chromatography was performed on sili-
ca gel (Merck Kieselgel 60) or Iatro Beads (60 Wm) (Dia-Iatron
Laboratories) when speci¢ed. Gel permeation chromatography
was performed using Bio Gel P-2. TLC spots were visualized
using 7% 12-molybdo(VI)phosphoric acid n-hydrate in EtOH.
A JEOL EX-270 spectrometer was used to obtain nuclear mag-
netic resonance (NMR) spectra at 25‡C. 1H NMR (270 MHz)
spectra were recorded in CDCl3 or D2O using Me4Si (N 0.00) or
DOH (N 4.80) as the internal standard. 13C NMR (67.5 MHz)
spectra were recorded in CDCl3 or D2O using Me4Si (N 0.0),
CDCl3 (N 77.0), or CD3CN (N 118.2) as the internal standard.
Only partial assignments were reported. MALDI-TOF mass spec-
tra were recorded on an Applied BioSystems Voyager with 2,5-
dihydroxybenzoic acid as matrix. Color development of TLC was
determined using the ATTO Densitograph software library Lane
Analyzer (ATTO Corp.).
4.3. General methods for glycosyltransfer reactions and analyses
Enzyme reactions were performed in a total volume of 250 Wl
in microtubes. The reaction mixture contained 0.1 M cacodylate
bu¡er (pH 7), 10 mM MnCl2, 0.1 mM UDP-Gal, 0.2 mM 4-MU-
glycoside, 0.5 mM inhibitor, and 20 mU/ml galactosyltransferase.
After incubation for 5 min at 37‡C, the reaction was terminated
by the addition of 50 Wl of 0.1 M borate and heating at 80‡C for
10 min. The resulting mixture was ¢nally ¢ltered with Millex GV
¢lter to remove the precipitate.
Kinetic analysis was performed on a Waters Quanta 4000E
capillary electrophoresis system, which was equipped with a fused
silica capillary of i.d. 75 Wm and length as speci¢ed. Samples were
loaded by means of hydrostatic pressure at 10 cm height for 10 s.
Detection was carried out by on-column measurement of UV
absorption at 214 nm at 7.5 cm from the cathode. Pherograms
were recorded on a Millennium 2010 system (Waters Corp.).
4.4. Typical procedure for reductive amination of compound 3
A solution of aldehyde 3 (9 mg, 0.017 mmol) in toluene (300
Wl), phenethylamine (4.4 Wl, 0.035 mmol) was added at 0‡C and
stirred at room temperature for 2 h, then 1 M solution of
NaBH3CN in THF (51.0 Wl, 3 equiv.) was added at 0‡C and
stirred at room temperature overnight. The mixture was diluted
with EtOAc, washed with saturated NaHCO3 and dried over
MgSO4. Conversion yields of reductive amination were estimated
by densitographic analyses of TLC, where spots were visualized
by molybdophosphate reagent. Only UV-positive spots corre-
sponding to the protected iminocyclitol were analyzed. Yields
(%): 4(1), 98.1; 4(2), 42.4; 4(3), 80.3; 4(4), 57.5; 4(5), 80.9;
4(6), 61.0; 4(7), 54.9; 4(8), 79.4; 4(9), 80.3. After removal of
the solvent, the residue was dissolved in MeOH (0.8 ml) and
1 M HCl (0.2 ml) and stirred with a catalytic amount of 20%
Pd(OH)2 on C under H2 atmosphere at room temperature for
2 days. The crude material, obtained after removal of the catalyst
and solvent, was dissolved in H2O (1 ml) and stirred with Dowex
1X8 (OH form) at room temperature for 30 min. After ¢ltration
and removal of the solvent, the residue was dissolved in H2O and
applied onto a Waters Sep-Pak Plus CM cartridge, which was
pretreated with 1 M HCl (10 ml) and water (20 ml). The cartridge
was washed with H2O (20 ml), after which elution with 10% NH3
(10 ml), ¢ltration through a Millex GV ¢lter, and lyophilization
gave 2(8,1) (2.5 mg, 53% from 3). In parallel reactions, 2(1,1)
(55%), 2(2,1) (65%), 2(3,1) (10%), 2(4,1) (80%), 2(5,1) (36%),
2(6,1) (74%), 2(7,1) (63%), 2(9,1) (29%) were obtained. Selected
physical data of these compounds are listed below.
2(1,1) : 1H NMR (D2O): N 4.20 (t, 1H, J = 3.8 Hz), 3.98 (dd,
1H, J = 4.0, 8.4 Hz), 3.84 (dd, 1H, J = 6.6, 11.2 Hz), 3.69 (dd, 1H,
J = 4.7, 11.2 Hz), 3.34 (dd, 1H, J = 3.5, 6.6 Hz), 0.96 (t, 3H,
J = 7.3 Hz, CH3); MALDI-TOF MS calcd. for C10H22N2O3 :
218; found: m/z 219 (M+H). 2(2,1) : 1H NMR (D2O): N 4.19
(t, 1H, J = 3.9 Hz), 3.91 (dd, 1H, J = 4.4, 8.6 Hz), 3.84 (dd, 1H,
J = 6.5, 10.9 Hz), 3.67 (dd, 1H, J = 6.6, 11.2 Hz), 2.66 (s, 6H,
N(CH3)2). 2(3,1) : 1H NMR (D2O): N 4.19 (t, 1H, J = 3.5 Hz),
3.97 (dd, 1H, J = 3.9, 7.8 Hz), 0.89 (t, 3H, J = 6.7 Hz, CH3);
MALDI-TOF MS calcd. for C16H34N2O3 : 302; found: m/z 303
(M+H). 2(4,1) : 1H NMR (D2O): N 4.19 (t, 1H, J = 3.8 Hz), 3.96
(dd, 1H, J = 4.3, 8.5 Hz); MALDI-TOF MS calcd. for
C8H18N2O4 : 206; found: m/z 207 (M+H). 2(5,1) : 1H NMR
(D2O): N 4.30 (t, 1H, J = 3.5 Hz), 4.19 (dd, 1H, J = 3.5, 8.6
Hz); MALDI-TOF MS calcd. for C16H28N2O3 : 296; found: m/z
297 (M+H). 2(6,1) ; 1H NMR (D2O): N 4.19 (t, 1H, J = 3.8 Hz),
3.94 (dd, 1H, J = 4.2, 8.3 Hz), 3.82 (dd, 1H, J = 6.8, 11.3 Hz), 3.67
(dd, 1H, J = 6.2, 11.3 Hz), 3.58 (t, 2H, J = 6.3 Hz), 3.38 (s, 3H,
OCH3), 2.93 (dd, 1H, J = 4.7, 12.2 Hz), 2.81 (t, 2H, J = 7.2 Hz),
1.85 (quintet, 2H, J = 6.8 Hz); MALDI-TOF MS calcd. for
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C10H22N2O4 : 234; found: m/z 235 (M+H). 2(7,1) : 1H NMR
(D2O): N 4.24 (t, 1H, J = 3.6 Hz), 4.19 (t, 1H, J = 3.7 Hz), 4.03
(dd, 1H, J = 4.1, 8.6 Hz); MALDI-TOF MS calcd. for
C11H22N2O4 : 246; found: m/z 247 (M+H). 2(8,1) : 1H NMR
(D2O): N 7.43^7.35 (m, 5H), 4.16 (t, 1H, J = 4.0 Hz), 3.90 (dd,
1H, J = 3.9, 8.2 Hz), 3.80 (dd, 1H, J = 6.9, 11.1 Hz); MALDI-
TOF MS calcd. for C14H22N2O3 : 266; found: m/z 267 (M+H).
2(9,1) ; 1H NMR (D2O): N 4.18 (t, 1H, J = 3.4 Hz), 3.96 (dd, 1H,
J = 4.4, 8.3 Hz), 3.82 (dd, 1H, J = 6.6, 10.8 Hz), 3.67 (dd, 1H,
J = 6.6, 10.5 Hz); MALDI-TOF MS calcd. for C12H24N2O3 : 244;
found: m/z 245 (M+H).
4.5. Typical procedure for Strecker reaction of compound 3
To a solution of aldehyde 3 (24 mg, 0.045 mmol) in toluene
(700 Wl), phenethylamine (6.9 Wl, 0.054 mmol) was added at 0‡C
and stirred at room temperature for 2 h, then TMSCN (18.1 Wl,
0.14 mmol) and 0.5 M solution of zinc chloride in THF (9.0 Wl,
0.1 equiv.) was added at 0‡C and stirred at room temperature
overnight. The mixture was diluted with EtOAc, washed with
saturated NaHCO3, and dried over MgSO4. After removal of
the solvent, the crude material of nitrile 5(8) (29 mg, 96.0%p
(6:4)) was obtained, where %p stands for purity of the product
in a crude mixture as estimated by densitographic analysis of
TLC, and the following number in parentheses indicates the ratio
of diastereoisomers. Those without the ratio indicate that the
stereoisomers had the same Rf values. Spots were visualized by
molybdophosphate reagent and only UV-positive spots corre-
sponding to protected iminocyclitol were analyzed. In parallel
reactions, 5(1) (43 mg, 81.9%p (1:1), from 3 (39 mg, 0.074
mmol)), 5(2) (26 mg, 58.2%p, from 3 (27 mg, 0.052 mmol)),
5(3) (27 mg, 91.2%p (6:4), from 3 (28 mg, 0.053 mmol)), 5(4)
(29 mg, 67.8%p, from 3 (27 mg, 0.051 mmol)), 5(5) (30 mg,
70.6%p, from 3 (24 mg, 0.046 mmol)), 5(6) (27 mg, 56.9%p
(6:4), from 3 (25 mg, 0.046 mmol)), 5(7) (26 mg, 87.5%p (6:4),
from 3 (26 mg, 0.048 mmol)) and 5(9) (30 mg, 57.0%p, from 3 (26
mg, 0.050 mmol)) were obtained. These compounds were used for
the next reaction without further puri¢cation. Selected physical
data are shown below.
5(1) : 1H NMR (CDCl3): N 3.62 (d, 1H, J = 8.4 Hz, CHCN),
1.43 (s, 9H, C(CH3)3), 0.91 (t, 3H, J = 7.0 Hz, CH3); 13C NMR
(CDCl3): 119.35 and 118.65 (CN), 80.99 (C(CH3)3), 28.29
(C(CH3)3), 13.84 (CH3); MALDI-TOF MS calcd. for
C37H47N3O5 : 613; found: m/z 614 (M+H). 5(2) : 1H NMR
(CDCl3): N 3.63 (d, 1H, J = 9.0 Hz, CHCN), 2.22 (s, 6H), 1.44
(s, 9H); MALDI-TOF MS calcd. for C37H48N4O5 : 628; found:
m/z 629 (M+H). 5(3) : 1H NMR (CDCl3): N 4.12 (t, 1H, J = 8.5
Hz), 3.63 (d, 1H, J = 8.5 Hz, CHCN), 1.43 (s, 9H), 0.88 (t, 3H,
J = 6.4 Hz); MALDI-TOF MS calcd. for C43H59N3O5 : 697;
found: m/z 698 (M+H), 720 (M+Na), 736 (M+K). 5(4) : 1H
NMR (CDCl3): N 1.44 (s, 9H); MALDI-TOF MS calcd. for
C35H43N3O6 : 601; found: m/z 602 (M+H), 624 (M+Na).
5(5) : 1H NMR (CDCl3): N 3.64 (d, 1H, J = 8.1 Hz, CHCN),
1.46 (s, 9H); MALDI-TOF MS calcd. for C43H53N3O5 : 691;
found: m/z 692 (M+H). 5(6) : 1H NMR (CDCl3): N 3.63 (d,
1H, J = 8.3 Hz, CHCN), 3.31 (s, 3H), 1.44 (s, 9H). 5(7) : 1H
NMR (CDCl3): N 3.63 (d, 1H, J = 7.5 Hz, CHCN), 1.43 (s,
9H); MALDI-TOF MS calcd. for C38H47N3O6 : 641; found: m/
z 642 (M+H). 5(8) : 1H NMR (CDCl3) : N 4.26 (dt, J = 2.5, 7.0
Hz, 1H), 3.94 (d, 2H, J = 4.1 Hz), 3.61 (t, 1H, J = 6.5 Hz), 1.44 (s,
9H); 13C NMR (CDCl3); 118.58 (CN), 81.00 (C(CH3)3), 28.14
(C(CH3)3); MALDI-TOF MS calcd. for C41H47N3O5 : 661;
found: m/z 662 (M+H). 5(9) : 1H NMR (CDCl3): N 4.14 (t,
1H, J = 8.3 Hz), 3.98 (d, 2H, J = 4.8 Hz), 3.63 (d, 1H, J = 6.6
Hz, CHCN), 1.45 (s, 9H); MALDI-TOF MS calcd. for
C39H49N3O5 : 639; found m/z 640 (M+H).
4.6. Typical transformation reaction of nitrile to amino group:
synthesis of compound 2(8,2)
To a solution of crude compound 5(8) (8 mg, corresponding to
2 (7 mg, 0.013 mmol)) dissolved in MeOH (0.8 ml) and 1 M HCl
(0.2 ml) a catalytic amount of 20% Pd(OH)2 on C was added.
The reaction mixture was stirred under H2 atmosphere at room
temperature for 4 days. The crude material, obtained after re-
moval of the catalyst and solvent, was dissolved in H2O (1 ml)
and stirred with Dowex 1X8 (OH form) at room temperature for
30 min. After ¢ltration and removal of the solvent, the residue
was dissolved in H2O and applied onto a Waters Sep-Pak Plus
CM cartridge pretreated with 1 M HCl (10 ml) and water (20 ml).
The cartridge was washed with H2O (20 ml), after which elution
with 10% NH3 (10 ml), ¢ltration through a Millex GV ¢lter, and
lyophilization gave 2(8,2) (2.3 mg, 58% from 3). In parallel reac-
tions were obtained 2(1,2) (51%), 2(2,2) (41%), 2(3,2) (8%), 2(4,2)
(41%), 2(5,2) (32%), 2(6,2) (31%), 2(7,2) (27%), 2(9,2) (12%). Se-
lected physical data are listed below.
2(1,2) : 1H NMR (D2O): N 0.90 (t, 3H, J = 6.5 Hz, CH3).
2(2,2) : 1H NMR (D2O): N 1.95 (s, 6H); 2(3,2) : MALDI-TOF
MS calcd. for C17H37N3O5 : 331; found: m/z 332 (M+H).
2(4,2) : 1H NMR (D2O): N 3.75 (t, J = 5.6 Hz), 3.00 (t, J = 5.6
Hz); MALDI-TOF MS calcd. for C9H21N3O4 : 235; found: m/z
236 (M+H), 274 (M+K). 2(5,2) : MALDI-TOF MS calcd. For
C17H31N3O3 : 325; found: m/z 326 (M+H). 2(8,2) : MALDI-TOF
MS calcd. for C15H25N3O3 : 295; found: m/z 296 (M+H).
2(9,2) : MALDI-TOF MS calcd. for C13H27N3O3 : 273; found:
m/z 274 (M+H), 312 (M+K).
4.7. Typical transformation reaction of nitrile to amide group:
synthesis of compound 2(1,3)
To a solution of crude compound 5(1) (8 mg, corresponding to
3 (10 mg, 0.018 mmol)) in MeOH (0.8 ml) and 6 M KOH (0.2 ml)
was added 30% H2O2 (17 Wl, 0.15 mmol). The reaction mixture
was stirred at 50‡C for 2 h. After cooling, the reaction mixture
was poured into ice-water and extracted with CH2Cl2, and dried
over MgSO4. To this residue dissolved in MeOH (0.8 ml) and 1 M
HCl (0.2 ml) a catalytic amount of 20% Pd(OH)2 on C was
added. The reaction mixture was stirred under H2 atmosphere
at room temperature for 3 days. The crude material, obtained
after removal of the catalyst and solvent, was dissolved in H2O
(1 ml) and stirred with Dowex 1X8 (OH form) at room temper-
ature for 30 min. After ¢ltration and removal of the solvent, the
residue was dissolved in H2O and applied onto a Waters Sep-Pak
Plus CM cartridge pretreated with 1 M HCl (10 ml) and water
(20 ml). The cartridge was washed with H2O (20 ml), after which
elution with 10% NH3 (10 ml), ¢ltration through a Millex GV
¢lter, and lyophilization gave 2(1,3) (1.4 mg, 28% from 3). In
parallel reactions were obtained 2(2,3) (42%), 2(3,3) (15%),
2(4,3) (33%), 2(5,3) (17%), 2(6,3) (28%), 2(7,3) (12%), 2(8,3)
(27%), 2(9,3) (26%). Selected physical data of these compounds
are listed below.
2(1,3) : 1H NMR (D2O): N 3.34 (t, J = 6.5 Hz), 0.92 (t, J = 6.2
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Hz); MALDI-TOF MS calcd. for C11H23N3O4 : 261; found: m/z
262 (M+H) ; before hydrogenolysis : MALDI-TOF MS calcd.
for C37H49N3O6 : 631; found: m/z 632 (M+H). 2(2,3) : MAL-
DI-TOF MS calcd. for C11H24N4O4 : 276; found: m/z 277
(M+H) ; before hydrogenolysis: MALDI-TOF MS calcd. for
C37H50N4O6 : 646; found: m/z 647 (M+H), 685 (M+K).
2(3,3) : 1H NMR (D2O): N 0.89 (t, 3H, J = 6.0 Hz); MALDI-
TOF MS calcd. for C17H35N3O4 : 345; found: m/z 346
(M+H). 2(4,3) : 1H NMR (D2O): N 3.00 (t, J = 5.2 Hz); MAL-
DI-TOF MS calcd. for C9H19N3O5 : 249; found: m/z 250
(M+H) ; before hydrogenolysis: MALDI-TOF MS calcd. for
C35H45N3O7 : 619; found: m/z 620 (M+H), 642 (M+Na).
2(5,3) : MALDI-TOF MS calcd. for C17H29N3O4 : 339; found:
m/z 340 (M+H) ; before hydrogenolysis : MALDI-TOF MS
calcd. for C43H55N3O6 : 709; found: m/z 710 (M+H). 2(6,3) :
1H NMR (D2O): N 3.54 (t, J = 6.3 Hz), 3.35 (s, 3H); MALDI-
TOF MS calcd. for C11H23N3O5 : 277; found: m/z 278 (M+H).
2(7,3) : MALDI-TOF MS calcd. for C12H23N3O5 : 289; found:
m/z 290 (M+H) ; before hydrogenolysis : MALDI-TOF MS calcd.
for C38H49N3O7 : 659; found: m/z 660 (M+H). 2(8,3) : MALDI-
TOF MS calcd. for C15H23N3O4 : 309; found: m/z 310 (M+H),
322 (M+Na) ; before hydrogenolysis : 1H NMR (CDCl3): N 6.58,
6.46, 5.39, 5.22 (br. s, CONH2); 13C NMR (CDCl3) N 175.20 and
174.68 (CONH2), 155.38 (NCOO), 28.38 (CH3); MALDI-TOF
MS calcd. for C41H49N3O6 : 679; found: m/z 680 (M+H).
2(9,3) : MALDI-TOF MS calcd. for C13H25N3O4 : 287; found:
m/z 288 (M+H) ; before hydrogenolysis : MALDI-TOF MS
calcd. for C39H51N3O6 : 657; found: m/z 658 (M+H).
4.8. Screening of library against glycosidases
Incubations were performed in microtiter plate wells (50 Wl/
well). Reaction mixtures contained suitable bu¡er (40 mM phos-
phate bu¡er (pH 7) for K-glucosidase, K-galactosidase and L-ga-
lactosidase, 20 mM acetate bu¡er (pH 5) for K-mannosidase, 40
mM citrate bu¡er (pH 4) for K-galactosaminidase), 1 mM PNP-
glycoside, various amounts of inhibitors (1 nM^1 mM) and gly-
cosidase (0.4 U/ml K-glucosidase, 0.2 U/ml K-galactosidase, 1 U/
ml L-galactosidase, 0.2 U/ml K-mannosidase, 0.6 U/ml K-galacto-
saminidase). In the case of compound 2(3,Y), a stock 5 mM so-
lution was ¢rst prepared by dissolving the compound in dimethyl
sulfoxide (DMSO) and dilution with H2O (H2O:DMSO = 6:1
(v/v)), and aliquots of the solution were used for each reaction.
After incubation at room temperature for 5 min, the reaction
was terminated by addition of 50 Wl of 0.2 M sodium carbonate.
Each experiment was carried out in duplicate. The inhibitory
results of a series of compounds in the library are shown in
Fig. 4A^F.
4.9. Assay of K-1,3-GalT-ase
Incubations were performed at pH 6.5 in the presence of K-1,3-
galactosyltransferase for varying times (1^15 min) for kinetic
analysis. Inhibitory assays of iminosugars against K-1,3-GalT-
ase were carried out under the same conditions as kinetic analysis
for 5 min in the presence of 0.5 mM iminosugars. None of these
iminosugars exhibited inhibitory activity against K-1,3-GalT-ase.
Electrophoresis was performed at 15 kV using a 60 cm fused
silica capillary. The migration times for acceptor 4-MU-LacNAc
(6) and product 4-MU-Gal-K(1C3)-Gal-L(1C4)-GlcNAc (7)
were 9.3 and 10.0 min, respectively. Mass spectrometric analysis
of the reaction mixture after Sep-Pak C18 gave satisfactory data.
MALDI-TOF MS: compound 6 : calcd. for C24H31NO13 : 541;
found: m/z 564 (M+Na) ; 7 : calcd. for C30H41NO18 : 703;
found: m/z 726 (M+Na).
4.10. Screening of library against L-1.4-GalT-ase
Incubations were performed at pH 7.0 in the presence of L-1,4-
GalT-ase for varying times (1^15 min) for kinetic analysis. Inhib-
itory assays of iminosugars were carried out under the same con-
ditions as kinetic analysis for 5 min in the presence of 0.5 mM
iminosugar. The inhibitory result is shown in Fig. 4G.
Electrophoresis was performed at 20 kV using a 49 cm fused
silica capillary. 50 mM sodium borate was used as the electrolyte.
The migration times for acceptor 4-MU-GlcNAc and product 4-
MU-LacNAc (6) were 2.4 and 2.6 min, respectively.
Acknowledgements
This research was preliminarily initiated at the Institute
of Physical and Chemical Research (RIKEN) as a project
of the Glycotechnology Team, Frontier Research Program
and thus the support in part from JSTA is acknowledged.
References
[1] R. Kornfeld, S. Kornfeld, Assembly of asparagin-linked oligosaccha-
rides, Annu. Rev. Biochem. 54 (1985) 631^664.
[2] I. Brockhausen, Pathways of O-glycan biosynthesis in cancer cells,
Biochim. Biophys. Acta 1473 (1999) 67^95.
[3] T.D. Butters, R.A. Dwek, F.M. Platt, Inhibition of glycosphingolipid
biosynthesis: Application to lysosomal storage disorders, Chem. Rev.
100 (2000) 4683^4696.
[4] M.L. Sinnott, Catalytic mechanisms of enzymic glycosyl transfer,
Chem. Rev. 90 (1990) 1171^1202.
[5] C.S. Rye, S.G. Withers, Glycosidase mechanisms, Curr. Opin. Chem.
Biol. 4 (2000) 573^580.
[6] U.M. Uº nligil, J.M. Rini, Glycosyltransferase structure and mecha-
nism, Curr. Opin. Struct. Biol. 10 (2000) 510^517.
[7] B. Winchester, S. Al Daher, N.C. Carpenter, I. Cenci Di Bello, S.S.
Choi, A.J. Fairbanks, G.W.J. Fleet, The structural basis of the inhi-
bition of human K-mannnosidases by azafuranose analogues of man-
nose, Biochem. J. 290 (1993) 743^749.
[8] G.W.J. Fleet, S.J. Nicholas, P.W. Smith, S.V. Evans, L.E. Fellows,
R.J. Nash, Potent competitive inhibition of K-galactosidase and K-
glucosidase activity by 1,4-dideoxy-1,4-iminopentitols : Syntheses of
1,4-dideoxy-1,4-imino-D-lyxitol and of both enantiomers of 1,4-di-
deoxy-1,4-iminoarabinitol, Tetrahedron Lett. 26 (1985) 3127^3130.
[9] K.K.-C. Liu, T. Kajimoto, L. Chen, Z. Zhong, Y. Ichikawa, C.-H.
Wong, Use of dihydroxyacetone phosphate dependent aldolases in
the synthesis of deoxyazasugars, J. Org. Chem. 56 (1991) 6280^6289.
[10] A. Kato, I. Adachi, M. Miyauchi, K. Ikeda, T. Komae, H. Kizu, Y.
Kameda, A.A. Watson, R.J. Nash, M.R. Wormald, G.W.J. Fleet, N.
Asano, Polyhydroxylated pyrrolidine and pyrrolizidine alkaloids
from Hyacinthoides non-scripta and Scilla campanulata, Carbohydr.
Res. 316 (1999) 95^103.
[11] M. Takebayashi, S. Hiranuma, Y. Kanie, T. Kajimoto, O. Kanie,
C.-H. Wong, A versatile synthetic strategy for the preparation and
discovery of new iminocyclitols as inhibitors of glycosidases, J. Org.
Chem. 64 (1999) 5280^5291.
CHBIOL 138 24-10-01 Cyaan Magenta Geel Zwart
Research Paper Combinatorial library of azasugar C. Saotome et al. 1069
[12] C. Saotome, Y. Kanie, O. Kanie, C.-H. Wong, Synthesis and enzy-
matic evaluation of ¢ve-membered iminocyclitols and pseudodisac-
charide, Bioorg. Med. Chem. 8 (2000) 2249^2261.
[13] T. Kajimoto, K.K.-C. Liu, R.L. Pederson, Z. Zhong, Y. Ichikawa,
J.A. Porco Jr., C.-H. Wong, Enzyme-catalyzed aldol condensation
for asymmetric synthesis of azasugars: Synthesis, evaluation, and
modeling of glycosidase inhibitors, J. Am. Chem. Soc. 113 (1991)
6187^6196.
[14] Y. Ichikawa, Y. Igarashi, M. Ichikawa, Y. Suhara, 1-N-Iminosugars:
Potent and selective inhibitors of L-glycosidases, J. Am. Chem. Soc.
120 (1998) 3007^3018.
[15] G. Legler, S. Pohl, Synthesis of 5-amino-5-deoxy-D-galactopyranose
and 1,5-dideoxy-1,5-imino-D-galactitol, and their inhibition of K- and
L-D-galactosidases, Carobydr. Res. 155 (1986) 119^129.
[16] C.-H. Wong, R.L. Halcomb, Y. Ichikawa, T. Kajimoto, Enzymes in
organic synthesis: Application to the problems of carbohydrate
recognition (Part 1), Angew. Chem. Int. Ed. Engl. 34 (1995) 412^
432.
[17] C.-H. Wong, R.L. Halcomb, Y. Ichikawa, T. Kajimoto, Enzymes in
organic synthesis : Application to the problems of carbohydrate rec-
ognition (Part 2), Angew. Chem. Int. Ed. Engl. 34 (1995) 521^546.
[18] A.B. Hughes, A.J. Rudge, Deoxynojirimycin: Synthesis and biologi-
cal activity, Nat. Prod. Rep. (1994) 135^162.
[19] X. Qian, M.M. Palcic, Glycosyltransferase inhibitors, in: B. Ernst,
G.W. Hart, P. Sinay« (Eds.), Carbohydrates in Chemistry and Biol-
ogy, Vol. 3, Wiley-VCH, Weinheim, 2000, pp. 293^312.
[20] U.J. Nilsson, E.J.-L. Fournier, O. Hindsgaul, Solid-phase extraction
on C18 silica as a puri¢cation strategy in the solution synthesis of a
1-thio-L-D-galactopyranoside library, Bioorg. Med. Chem. 6 (1998)
1563^1575.
[21] R. Wischnat, R. Martin, S. Takayama, C.-H. Wong, Chemoenzy-
matic synthesis of iminocyclitol derivatives : A useful library strategy
for the development of selective fucosyltransfer enzymes inhibitors,
Bioorg. Med. Chem. Lett. 8 (1998) 3353^3358.
[22] A. Lohse, K.B. Jensen, K. Lundgren, M. Bols, Synthesis and decon-
volution of the ¢rst combinatorial library of glycosidase inhibitors,
Bioorg. Med. Chem. 7 (1999) 1965^1971.
[23] A. Lohse, K.B. Jensen, M. Bols, The ¢rst combinatorial library of
azasugar glycosidase inhibitors, Tetrahedron Lett. 40 (1999) 3033^
3036.
[24] M. Takayanagi, T. Flessner, C.-H. Wong, A strategy for the solution-
phase parallel synthesis of N-(pyrrolidinylmethyl)hydroxamic acids,
J. Org. Chem. 65 (2000) 3811^3815.
[25] C. Malet, O. Hindsgaul, Generation of molecular diversity on N-
acetyllactosamine via O-cyanomethyl ethers, Carbohydr. Res. 303
(1997) 51^65.
[26] F. Balkenhohl, C. von dem Bussche-Hunefeld, A. Lansky, C. Zechel,
Combinatorial synthesis of small organic molecules, Angew. Chem.
Int. Ed. Engl. 35 (1996) 2288^2337.
[27] R. Murali, Y.A. Ioannou, R.J. Desnick, R.M. Burnett, Crystalliza-
tion and preliminary X-ray analysis of human K-galactosidase A
complex, J. Mol. Biol. 239 (1994) 578^580.
[28] R.H. Jacobson, X.-J. Zhang, R.F. DuBose, B.W. Matthews, Three-
dimensional structure of L-galactosidase from E. coli, Nature 369
(1994) 761^766.
[29] L.N. Gastinel, C. Cambillau, Y. Bourne, Crystal structures of the
bovine L4-galactosyltransferase catalytic domain and its complex
with uridine diphoshogalactose, EMBO J. 18 (1999) 3546^3557.
[30] J.C.M. Uitdehaag, R. Mosi, K.H. Kalk, B.A. van der Veen, L. Dijk-
huizen, S.G. Withers, B.W. Dijkstra, X-ray structures along the re-
action pathway of cyclodextrin glycosyltransferase elucidate catalysis
in the K-amylase family, Nature Struct. Biol. 6 (1999) 432^436.
[31] F. Valle¤e, F. Lipari, P. Yip, B. Sleno, A. Herscovics, P.L. Howell,
Crystal structure of a class I K1,2-mannosidase involved in N-glycan
processing and endoplasmic reticulum quality control, EMBO J. 19
(2000) 581^588.
[32] G.W.J. Fleet, A. Karpas, R.A. Dwek, L.E. Fellows, A.S. Tyms, S.
Petursson, S.K. Namgoong, N.G. Ramsden, P.W. Smith, J.C. Son,
F. Wilson, D.R. Witty, G.S. Jacob, T.W. Rademacher, Inhibition of
HIV replication by amino-sugar derivatives, FEBS Lett. 237 (1988)
128^132.
[33] A. Karpas, G.W.J. Fleet, R.A. Dwek, S. Petursson, S.K. Namgoong,
N.G. Ramsden, G.S. Jacob, T.W. Rademacher, Aminosugar deriva-
tives as potential anti-human immunode¢ciency virus agents, Proc.
Natl. Acad. Sci. USA 85 (1988) 9229^9233.
[34] N. Asano, H. Kizu, K. Oseki, E. Tomioka, K. Matsui, M. Okamoto,
M. Baba, N-Alkylated Nitrogen-in-the-Ring Sugars: Comformation-
al Basis of Inhibition of Glycosidases and HIV-1 Replication, J. Med.
Chem. 38 (1995) 2349^2356.
[35] I. Ojima, S. Inaba, Asymmetric syntheses of K-aminonitriles via cy-
anosilylation of Schi¡ bases, Chem. Lett. (1975) 737^740.
[36] A. Sharma, J. Okabe, P. Birch, S.B. McClellan, M.J. Martin, J.L.
Platt, J.S. Logan, Reduction in the level of Gal(K1,3)Gal in trans-
genic mice and pigs by the expression of an K(1,2)fucosyltransferase,
Proc. Natl. Acad. Sci. USA 93 (1996) 7190^7195.
[37] K. Sujino, C. Malet, O. Hindsgaul, M.M. Palcic, Acceptor hydroxy
group mapping for calf thymus K-(1C3)-galactosyltransferase and
enzymatic synthesis of K-D-Galp-(1C3)-L-D-Galp-(1C4)-L-D-
GlcpNAc analogs, Carbohydr. Res. 305 (1998) 483^489.
[38] X. Chen, P.R. Andreana, P.G. Wang, Carbohydrates in transplanta-
tion, Curr. Opin. Chem. Biol. 3 (1999) 650^658.
[39] S. Takayama, S.J. Chung, Y. Igarashi, Y. Ichikawa, A. Sepp, R.I.
Lechler, J. Wu, T. Hayashi, G. Siuzdak, C.-H. Wong, Selective inhi-
bition of L-1,4- and K-1,3-galactosyltransferases : Donor sugar-nucle-
otide based approach, Bioorg. Med. Chem. 7 (1999) 401^409.
[40] Y. Kanie, A. Kirsch, O. Kanie, C.-H. Wong, Enzymatic assay of
galactosyltransferase by capillary electrophoresis, Anal. Biochem.
263 (1998) 240^245.
[41] Y. Nishimura, T. Satoh, T. Kudo, S. Kondo, T. Takeuchi, Synthesis
and Activity of 1-N-Iminosugar Inhibitors, Siastatin B Analogues for
K-N-Acetylgalactosaminidase and L-N-Acetylglucosaminidase, Bio-
org. Med. Chem. 4 (1996) 91^96.
[42] N. Yamamoto, V.R. Naraparaju, M. Urade, Prognostic utility of
serum K-N-acetylgalactosaminidase and immunosuppression resulted
from deglycosylation of serum Gc protein in oral cancer patients,
Cancer Res. 57 (1997) 295^299.
CHBIOL 138 24-10-01 Cyaan Magenta Geel Zwart
1070 Chemistry & Biology 8/11 (2001) 1061^1070
